Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Richard Horton on the Oxford vaccine phase 3 trial

Richard Horton on the Oxford vaccine phase 3 trial

FromThe Lancet in conversation with


Richard Horton on the Oxford vaccine phase 3 trial

FromThe Lancet in conversation with

ratings:
Length:
12 minutes
Released:
Dec 8, 2020
Format:
Podcast episode

Description

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.
Released:
Dec 8, 2020
Format:
Podcast episode

Titles in the series (100)

Our Editors and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.